culture
Tercer revés para Novartis en pocos días: la farmacéutica se derrumba en Bolsa tras los malos resultados de un medicamento muscular
Summary by Latinas Media Editorial Desk Cecilia Castelló Llantada , as published by El País
· September 8, 2026
· 1 min read
Photo: El País · view original
Story provenance No corrections
Summary created by Latinas Media Editorial Desk — automated, rule-governed Byline on source page Cecilia Castelló Llantada, as published by El País Original story Read at the source Source published Sep 8, 2026 Indexed here Sep 8, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway La noticia ha afectado negativamente la cotización de la farmacéutica suiza en Bolsa, que ha caído más de un 9%.
Un medicamento experimental para trastornos musculares no ha dado los resultados esperados. La noticia ha afectado negativamente la cotización de la farmacéutica suiza en Bolsa, que ha caído más de un 9%. Esto supone un nuevo revés para la compañía, que ya había sufrido otros dos en pocos días.
La situación se ha complicado debido a la falta de éxito de otros tratamientos. Se puede encontrar más información sobre estos acontecimientos en la publicación original. La farmacéutica suiza está pasando por un momento difícil tras estos fracasos consecutivos.
Por qué importa
El País reported and published this story. Latinas Media selected it, summarised the key facts above, and links to the original. We did not report this story and we added no reporting of our own to it.
Sobre esta historia
As published by El País . Latinas Media selects stories from publishers’ feeds, summarises them, and links back to the publisher that reported them. We add no reporting of our own. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit El País . Have a tip or correction? Contact the editor .
Category: culture Published: September 8, 2026 Source: El País Reading time: 1 min
Get more Latinas Media stories like this
Free weekly briefing covering culture and other local news. Curated by our editorial team. No spam.
By subscribing you agree to our privacy policy . Unsubscribe anytime.
Frequently asked about this story
What is this story about? Un medicamento experimental para trastornos musculares no ha dado los resultados esperados. La noticia ha afectado negativamente la cotización de la farmacéutica suiza en Bolsa, que ha caído más de…
When was this published? This article was first published on September 8, 2026 by El País and curated for Latinas Media readers.
Who reported this story? This story was reported by Cecilia Castelló Llantada at El País. To learn more about how Latinas Media selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more culture coverage from Latinas Media, or browse our daily briefing and topic hubs .
← Back to all news
More culture →
Today’s briefing
Subscribe to newsletter
